Immunogenicity and Protective Efficacy in Mice and Hamsters of a β-Propiolactone Inactivated Whole Virus SARS-CoV Vaccine-Reference-Cited by-同舟云学术

Immunogenicity and Protective Efficacy in Mice and Hamsters of a β-Propiolactone Inactivated Whole Virus SARS-CoV Vaccine

Published:2010-10 Issue:5 Volume:23 Page:509-519
ISSN:0882-8245
Container-title:Viral Immunology
language:en
Short-container-title:Viral Immunology

Author:

Roberts Anjeanette¹²,Lamirande Elaine W.¹,Vogel Leatrice¹,Baras Benoît³,Goossens Geneviève³,Knott Isabelle³,Chen Jun¹,Ward Jerrold M.⁴²,Vassilev Ventzislav³,Subbarao Kanta¹

Affiliation:

1. Laboratory of Infectious Diseases, (NIAID), National Institutes of Health (NIH), Bethesda, Maryland.

2. University of Virginia, Charlottesville, Virginia; JMW: Laboratory of Immunopathology, NIH, Bethesda, Maryland.

3. GlaxoSmithKline Biologicals, Rixensart, Belgium.

4. Comparative Medicine Branch, (NIAID), National Institutes of Health (NIH), Bethesda, Maryland.

Publisher

Mary Ann Liebert Inc

Subject

Virology,Molecular Medicine,Immunology

Link

https://www.liebertpub.com/doi/pdf/10.1089/vim.2010.0028

Reference35 articles.

1. Severe acute respiratory syndrome

2. Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern China

3. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats

4. Bats Are Natural Reservoirs of SARS-Like Coronaviruses

5. Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delving into revolutionary SARS-CoV-2 vaccine approaches: Molecular and virological examinations; principles of SARS-CoV-2 vaccine platform;Vacunas (English Edition);2024-01

2. Vaccine adjuvants and carriers;Advanced Vaccination Technologies for Infectious and Chronic Diseases;2024

3. Development of a new vaccine at the laboratory scale;Bioreactor Design Concepts for Viral Vaccine Production;2024

4. Delving into revolutionary SARS-CoV-2 vaccine approaches: Molecular and virological examinations; principles of SARS-CoV-2 vaccine platform;Vacunas;2023-11

5. β-Propiolactone (BPL)-inactivation of SARS-Co-V-2: In vitro validation with focus on saliva from COVID-19 patients for scent dog training;Journal of Virological Methods;2023-07